While IL-2 remained the most frequently used single cytokine in activation and expansion protocols, a notable trend emerged in the development of memory-like NK cells through combined stimulation with IL-12, IL-15, and IL-18.
← all excerpts
A systematic review of the last two decades of NK cell-based clinical trials: state of the art of AML therapy.
1
—
—